Начало › Рак на белия дроб › Кънектикът › New Haven
Клинични проучвания за Рак на белия дроб в New Haven, CT
22 проучвания за Рак на белия дроб търсят участници в обекти в и около New Haven (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Набиране на участнициФаза 3
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · на 3 мили
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Набиране на участнициФаза 3
- Yale University, New Haven
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · на 3 мили
- Yale-New Haven Hospital North Haven Medical Center, North Haven · на 7 мили
- и още 2
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Набиране на участнициФаза 3
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · на 7 мили
- Smilow Cancer Hospital-Derby Care Center, Derby · на 8 мили
- и още 1
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Набиране на участнициФаза 1/2
- Yale Cancer Center, New Haven
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 2
- Yale Cancer Center, New Haven
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Набиране на участнициФаза 3
- Yale University, Smillow Cancer Center, New Haven
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Набиране на участнициФаза 1
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
- и още 1
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Набиране на участнициФаза 2
- Research Site, New Haven
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
Набиране на участнициФаза 1/2
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · на 7 мили
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Набиране на участнициФаза 1
- Yale Cancer Center, New Haven
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Набиране на участнициФаза 1/2
- Yale University School of Medicine - Yale Cancer Center, New Haven
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Набиране на участнициФаза 3
- Yale University School of Medicine, New Haven
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Набиране на участнициФаза 1/2
- Avenzo Therapeutics Recruiting Site, New Haven
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Набиране на участнициФаза 1
- Yale Cancer Center, New Haven
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Набиране на участнициФаза 1
- Xencor Investigative Site, New Haven
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Набиране на участнициФаза 1/2
- Yale University Cancer Center, New Haven
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Набиране на участнициФаза 2
- Yale University, New Haven
- Smilow Cancer Hospital-Orange Care Center, Orange · на 5 мили
- Yale-New Haven Hospital North Haven Medical Center, North Haven · на 7 мили
- и още 2
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Набиране на участнициФаза 1
- Smilow Cancer Hospital (Yale University), New Haven
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Набиране на участнициФаза 2/3
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · на 7 мили
- Smilow Cancer Hospital-Derby Care Center, Derby · на 8 мили
- и още 1
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Набиране на участнициФаза 2
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · на 7 мили
- Smilow Cancer Hospital-Derby Care Center, Derby · на 8 мили
- и още 1
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
Набиране на участнициЗдравите доброволци са добре дошли
- Yale New Haven Medical Center, New Haven
The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)
Набиране на участнициНаблюдателно проучване
- Yale School of Medicine, New Haven
Проучвания за Рак на белия дроб в други градове
- Houston, TX78 проучвания
- Boston, MA62 проучвания
- New York City, NY60 проучвания
- Los Angeles, CA45 проучвания
- Arlington, VA41 проучвания
- Washington, DC41 проучвания
- Chicago, IL41 проучвания
- Baltimore, MD40 проучвания
- Nashville, TN40 проучвания
- St. Louis, MO39 проучвания
- Columbus, OH37 проучвания
- Philadelphia, PA36 проучвания
Други проучвания в New Haven
- Рак на белия дроб с недребноклетъчен тип41 проучвания
- Рак на гърдата38 проучвания
- Рак (всички видове)33 проучвания
- Метастатичен рак23 проучвания
- Плоскоклетъчен карцином на главата и шията22 проучвания
- Рак на яйчниците21 проучвания
- Колоректален рак20 проучвания
- Рак на простатата20 проучвания
- Остра миелоидна левкемия17 проучвания
- Разстройство при употреба на алкохол (AUD)17 проучвания
- Предозиране с опиати17 проучвания
- Рак на панкреаса16 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.